131 related articles for article (PubMed ID: 36181911)
21. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.
Murrough JW; Iosifescu DV; Chang LC; Al Jurdi RK; Green CE; Perez AM; Iqbal S; Pillemer S; Foulkes A; Shah A; Charney DS; Mathew SJ
Am J Psychiatry; 2013 Oct; 170(10):1134-42. PubMed ID: 23982301
[TBL] [Abstract][Full Text] [Related]
22. D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression.
Moaddel R; Luckenbaugh DA; Xie Y; Villaseñor A; Brutsche NE; Machado-Vieira R; Ramamoorthy A; Lorenzo MP; Garcia A; Bernier M; Torjman MC; Barbas C; Zarate CA; Wainer IW
Psychopharmacology (Berl); 2015 Jan; 232(2):399-409. PubMed ID: 25056852
[TBL] [Abstract][Full Text] [Related]
23. Effects of Serial Ketamine Infusions on Corticolimbic Functional Connectivity in Major Depression.
Vasavada MM; Loureiro J; Kubicki A; Sahib A; Wade B; Hellemann G; Espinoza RT; Congdon E; Narr KL; Leaver AM
Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jul; 6(7):735-744. PubMed ID: 32900657
[TBL] [Abstract][Full Text] [Related]
24. Association between depression subtypes and response to repeated-dose intravenous ketamine.
Wang C; Zhou Y; Zheng W; Liu W; Zhan Y; Li H; Chen L; Zhang B; Walter M; Li M; Li MD; Ning Y
Acta Psychiatr Scand; 2019 Nov; 140(5):446-457. PubMed ID: 31483855
[TBL] [Abstract][Full Text] [Related]
25. Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion.
Pennybaker SJ; Niciu MJ; Luckenbaugh DA; Zarate CA
J Affect Disord; 2017 Jan; 208():560-566. PubMed ID: 27839782
[TBL] [Abstract][Full Text] [Related]
26. Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial.
Phillips JL; Norris S; Talbot J; Birmingham M; Hatchard T; Ortiz A; Owoeye O; Batten LA; Blier P
Am J Psychiatry; 2019 May; 176(5):401-409. PubMed ID: 30922101
[TBL] [Abstract][Full Text] [Related]
27. Functional Dysconnectivity of Frontal Cortex to Striatum Predicts Ketamine Infusion Response in Treatment-Resistant Depression.
Chen MH; Chang WC; Lin WC; Tu PC; Li CT; Bai YM; Tsai SJ; Huang WS; Su TP
Int J Neuropsychopharmacol; 2020 Dec; 23(12):791-798. PubMed ID: 32726408
[TBL] [Abstract][Full Text] [Related]
28. Relationship between hippocampal volume and inflammatory markers following six infusions of ketamine in major depressive disorder.
Zhou YL; Wu FC; Wang CY; Zheng W; Lan XF; Deng XR; Ning YP
J Affect Disord; 2020 Nov; 276():608-615. PubMed ID: 32871692
[TBL] [Abstract][Full Text] [Related]
29. Neurocognitive effects of repeated ketamine infusion treatments in patients with treatment resistant depression: a retrospective chart review.
Dai D; Miller C; Valdivia V; Boyle B; Bolton P; Li S; Seiner S; Meisner R
BMC Psychiatry; 2022 Feb; 22(1):140. PubMed ID: 35193541
[TBL] [Abstract][Full Text] [Related]
30. Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder.
Niciu MJ; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Furey ML; Zarate CA
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539512
[TBL] [Abstract][Full Text] [Related]
31. Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression.
Shiroma PR; Johns B; Kuskowski M; Wels J; Thuras P; Albott CS; Lim KO
J Affect Disord; 2014 Feb; 155():123-9. PubMed ID: 24268616
[TBL] [Abstract][Full Text] [Related]
32. A preliminary study of adjunctive ketamine for treatment-resistant bipolar depression.
Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Lan XF; Zhang B; Ning YP
J Affect Disord; 2020 Oct; 275():38-43. PubMed ID: 32658821
[TBL] [Abstract][Full Text] [Related]
33. Low-dose ketamine infusion in treatment-resistant double depression: Revisiting the adjunctive ketamine study of Taiwanese patients with treatment-resistant depression.
Chen MH; Wu HJ; Li CT; Lin WC; Tsai SJ; Hong CJ; Tu PC; Bai YM; Mao WC; Su TP
Hum Psychopharmacol; 2022 Mar; 37(2):e2820. PubMed ID: 34597436
[TBL] [Abstract][Full Text] [Related]
34. Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression.
Park M; Newman LE; Gold PW; Luckenbaugh DA; Yuan P; Machado-Vieira R; Zarate CA
J Psychiatr Res; 2017 Jan; 84():113-118. PubMed ID: 27718369
[TBL] [Abstract][Full Text] [Related]
35. Functional connectivity between the habenula and default mode network and its association with the antidepressant effect of ketamine.
Wang M; Chen X; Hu Y; Zhou Y; Wang C; Zheng W; Liu W; Lan X; Ning Y; Zhang B
Depress Anxiety; 2022 May; 39(5):352-362. PubMed ID: 34964207
[TBL] [Abstract][Full Text] [Related]
36. A single infusion of ketamine improves depression scores in patients with anxious bipolar depression.
Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Zarate CA
Bipolar Disord; 2015 Jun; 17(4):438-43. PubMed ID: 25400146
[TBL] [Abstract][Full Text] [Related]
37. Functional connectivity of the amygdala and the antidepressant and antisuicidal effects of repeated ketamine infusions in major depressive disorder.
Liu H; Wang C; Lan X; Li W; Zhang F; Fu L; Ye Y; Ning Y; Zhou Y
Front Neurosci; 2023; 17():1123797. PubMed ID: 36816116
[TBL] [Abstract][Full Text] [Related]
38. Whole blood transcriptional signatures associated with rapid antidepressant response to ketamine in patients with treatment resistant depression.
Cathomas F; Bevilacqua L; Ramakrishnan A; Kronman H; Costi S; Schneider M; Chan KL; Li L; Nestler EJ; Shen L; Charney DS; Russo SJ; Murrough JW
Transl Psychiatry; 2022 Jan; 12(1):12. PubMed ID: 35013133
[TBL] [Abstract][Full Text] [Related]
39. Age affects temporal response, but not durability, to serial ketamine infusions for treatment refractory depression.
Pennybaker S; Roach BJ; Fryer SL; Badathala A; Wallace AW; Mathalon DH; Marton TF
Psychopharmacology (Berl); 2021 Nov; 238(11):3229-3237. PubMed ID: 34363507
[TBL] [Abstract][Full Text] [Related]
40. Distinct trajectories of antidepressant response to intravenous ketamine.
O'Brien B; Lijffijt M; Lee J; Kim YS; Wells A; Murphy N; Ramakrishnan N; Swann AC; Mathew SJ
J Affect Disord; 2021 May; 286():320-329. PubMed ID: 33770540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
